SelectScience
Join Free
NewsClinical Diagnostics

The Future of Drug Delivery Systems: Advancing New Technologies & Partnering Strategies

Appel Consulting
8 Nov 2011

Product news

A reminder that the Drug Delivery Summit 2011 meeting will be taking place in London this November (21st-22nd). So register now to secure your place at this meeting with the opportunity to hear exclusive speakers in the field of Drug Delivery.

The early registration deadline for the meeting is this Friday 11th November and you can receive up to £200 off standard prices until that date.

If you have not yet seen the meeting agenda, download the brochure following the company article page.

As a reminder, a sample of participants that have confirmed their presentations, include:
• Dr Sanjay Jain, Director of Biologic Research, Lipoxen plc
• Dr Carlos Velez , Business Development Director , Lacerta Bio
• Dr Tim Harper, Medical Consultant, Cientifica
• Dr Cristina Freire, Business Development Manager, Kucept
• Prof Giuseppe Battaglia, Biomedical Science, University of Sheffield
• Dr Jag Shur, Research Fellow, University of Bath
• Dr Michael Keller, Senior Fellow, Novartis
• Dr John Tsibouklis, Biomaterials & Drug Delivery Research Group, University of Portsmouth,
• Dr Richard Toon, Business Development Manager, Nemaura Pharma
• Dr Suzanne.R. Saffie-Siebert , CEO , SiSaf Ltd
• Dr Adam C. Watkinson , Director , Storith Consulting Limited,
• Dr Michael O Rouke , Consultant , Scotia Vision
• Dr Suzanne.R. Saffie-Siebert , Business Development Manager, Nemaura Pharma

A full list of speakers is available on the website or on the meeting brochure.

To register your place simply email sabrina.daw@appelconsulting.co.uk and quote the booking code: DD80 and you will be eligible for the final early bird discounts.

Alternatively Call: +44(0) 207 074 8900

Links

Appel ConsultingCompany website

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Drug DosageDosage is the size or frequency of the administration of a drug. Determination of the dosage of a drug is critical in pharmaceutical development to ensure the optimum balance between efficacy and toxicity.

Related articles

The Future of Drug Delivery Systems: Advancing New Technologies & Partnering Strategies